image description

News. Other News

Jumpstart, RiverVest Venture Partners to invest $750,000 in Securus Medical Group

Securus Medical Group
Crain’s, August 1, 2011
Jumpstart Inc. and RiverVest Venture Partners have announced plans to invest a total of $750,000 in Securus Medical Group, a biomedical technology startup that moved to Cleveland from Boston in July.

Frantz Medical Group Subsidiary, VasoStar, Awarded $1 Million Research Grant

VasoStar
Franz Medical, July 20, 2011
VasoStar develops a guidewire/catheter system for revascularization of completely occluded arteries as alternative to invasive surgical procedures.

Rainbow Medical in strategic cooperation with Cleveland Clinic

Rainbow Medical
Globes online, May 25, 2011
Rainbow Medical will offer Cleveland Clinic early-stage products and concepts for testing by the hospital’s staff.

Forest Labs to buy anti-arrhythmia drug from Blue Ash Therapeutics

Blue Ash Therapeutics
MedCity News, April 19, 2011
Cincinnati-based Blue Ash Therapeutics has reached an agreement in which Forest Laboratories will purchase the rights to an anti-arrhythmia drug the Ohio firm has been developing.

Smooth landings for Israelis in Ohio

Sensible Medical
Israel 21c, January 12, 2011
With more clinical trials by Israeli biomed firms being held in Ohio than in any other state, it’s clear that its priority to woo Israel businesses is bearing fruit.

CardioInsight Technologies Inc. strikes deal with Japanese distributor

CardioInsight
Crain’s, January 6, 2011
CardioInsight Technologies Inc. has struck a deal with a Japanese distributor that will invest in the Cleveland-based company and work to commercialize its medical imaging technology in Japan.

NI Medical’s technology to be used in big European heart study

NI Medical
MedCity News, October 19, 2010
NI Medical’s diagnostic device will be used in a far-ranging European Union-funded clinical study of heart disease and heart failure patients.

Global Cardiovascular Innovation Center